The Washington Post (predictably) headlined the move, “Trump administration imposes new restrictions on fetal tissue research.”
A more measured and accurate statement is that upon review, the Administration is taking additional steps to ensure that the National Institutes of Health (NIH) will not be funding its own research that uses tissue from elective abortions and will continue to pursue the development of ethical alternatives. In a six-paragraph explanation, HHS noted that last September the Department of Health and Human Services (HHS) terminated a contract between Advanced Bioscience Resources, Inc. and the Food and Drug Administration that provided human fetal tissue from elective abortions to develop testing protocols. The Department was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements. As a result, HHS also initiated a comprehensive review of […]
Click here to view the original web page at www.lifenews.com
